期刊文献+

缺血修饰白蛋白在运动压力测试中的应用探讨

The application discussion of Isehemia - modified albumin (IMA) in exercise stress tests
暂未订购
导出
摘要 目的评估冠状动脉疾病患者进行运动压力测试后血液中缺血修饰白蛋白的水平。方法选取本院49例一周内出现胸痛的患者,进行冠脉造影与单车运动压力测试,采集开始运动测试时的血液样本测试缺血修饰白蛋白,作为基线水平,5分钟后再次采样测试缺血修饰白蛋白水平。结果49例患者中,共中有25例(冠状动脉疾病组)有冠状动脉狭窄,另外24例(非冠状动脉疾病组)无冠状动脉狭窄。而缺血修饰白蛋白水平在基线水平与运动水平并无差异,冠状动脉疾病纽与非冠状动脉疾病组基线水平分别为70.7±7.2U/mL、72.5±6.4U/mL,而运动后水平为74.1±5.1、75.8±6.8U/mL,冠状动脉疾病组与非冠状动脉疾病组对比结果分别为P=0.28,P=0.55,二者无明显统计学差异。同时在运动后缺血修饰白蛋白水平变化值两组分别为5.4±3.5、4.7±7.6U/mL,P=0.10;同样的,在心电图阳性组(16例)与心电图阴性组(33例)缺血修饰白蛋白水平变化也无明显差异(6.6±3.IU/mL、7.50±4.2U/mL,P=0.15)。结论缺血修饰白蛋白在运动测试中对于急性冠脉综舍症的诊断并不适用。 Objective We examined the-ischemia- modified albumin (IMA) level during exercise in patients with coronary artery disease (CAD). Methods 47 patients with a history of chest pain underwent both symptom - limited treadmill exercise stress testing and coronary an- giography within one week. During the treadmill tests, blood samples were obtained at baseline and 5 min after exercise to measure the serum IMA level. Results Of the 47 patients, 25 (53%, CAD group) had significant coronary artery stenosis, while the other 24 (47%, non - CAD group) did not. The baseline and post - exercise IMA levels in the two groups did not differ significantly (70.7 ± 7.2 U/mL,72.5±6.4U/mL at basehne and 74.1 ± 5.1,75.8 ± 6.8U/mL at post - exercise in the CAD and non - CAD groups, p = 0.28 and 0.55, respectively). The changes in IMA after exercise did not differ either 5.4 ±3.544.7 ±7.6U/mL in the CAD and non - CAD groups, respectively, p = 0.10). Similarly, the change in IMA between the exercise EGG test positive (TMT positive, n = 16) and negative (TMT negative, n = 33) groups did not differ (6.6± 3.1 U/mL,7.50± 4.2 U/mL, p = 0.15, in the TMT positive and negative groups, respectively). Conclusions Our results suggest that IMA has limitation in detecting myocardial ischemia during symptom - limited exercise stress tests.
作者 廖其元
出处 《医学检验与临床》 2012年第2期13-15,共3页 Medical Laboratory Science and Clinics
关键词 缺血修饰白蛋白(IMA) 运动压力测试 缺血性心脏病 Ischemia- modified albumin Exercise stress tests Ischemic heart disease
  • 相关文献

参考文献9

  • 1Sinha MK,Roy D,Gaze DC,Collinson PO,Kaski IC. Role of "Ischemia modified albumin",a new biochemical marker of myocardial ischaemia,in the early diagnosis of acute coronary syndromees[J].Emery Med,2004.29-34.
  • 2Wu AH. The ischemia-modified albumin biomarker for myocardial isehemia[J].MLO:Medical Laboratory Observer,2003.36-40.
  • 3Kim KS,Shin SD,Song KJ,Sub GJ,Shin S. Prognosis of patients with out-of-hospital cardiac arrest and early biochemical markers:ischemia modified albumin,procalictonin,and S-100 protein[J].Korean Soc Emerg Med,2006.281-290.
  • 4Sbarouni E,Georgiadou P,Theodorakis GN,Kremastinos DT. Ischemia-modified albumin in relaltion to exercise stress testing[J].Journal of the American College of Cardiology,2006.2482-2484.
  • 5刘泽金,郑芳.缺血修饰白蛋白的临床应用进展[J].微循环学杂志,2010,20(1):52-55. 被引量:2
  • 6SacchettiA. " Iachemia modified albumin":a new biochemical marker of myocardial ischaemia[J].Emergency Medicine,2004.3-4.
  • 7荣嵘,洪岩,贾玫.冠心病患者血清缺血修饰白蛋白及心肌损伤标志物的变化和意义[J].中国实验诊断学,2010,14(3):405-407. 被引量:5
  • 8Zapieo-Mu?izE,Santa16-BelM,Mercé-Munta?olaJ,MontielJA.Martínez-RubioA,Ordonez-LlanoaJ. Iachemia-modified albumin during skeletal muscle ischemia[J].Clinical Chemistry,2004.1063-1065.
  • 9夏勇,吴宗华,林革,张伟雯,林丽英.缺血修饰白蛋白在急性冠脉综合征早期诊断中的价值[J].中国实验诊断学,2010,14(9):1411-1414. 被引量:14

二级参考文献49

  • 1陈磊,黄振文,牛青原,李素姣,郭攀.在急性冠状动脉综合征早期缺血修饰白蛋白的改变及其意义[J].临床荟萃,2006,21(9):617-620. 被引量:14
  • 2倪隽,朱健华,鞠少卿,苏建友,于小红,盛红专,王惠民.缺血修饰白蛋白与冠状动脉狭窄程度分析[J].天津医药,2007,35(3):219-220. 被引量:6
  • 3朱健华,倪隽,鞠少卿,苏建友,于小红,盛红专,王惠民.缺血修饰白蛋白在急性心肌缺血及心肌梗死患者中的诊断意义[J].临床荟萃,2007,22(9):616-618. 被引量:6
  • 4贾克刚,韩雪晶,唐红霞,南芳,张淑菊.应用全自动生化分析仪测定缺血修饰白蛋白[J].检验医学,2007,22(3):320-323. 被引量:21
  • 5Collinson PO, Gaze DC. Biomarkers of Cardiovascular Damage. Med Princ Pract, 2007,16(4) : 247-261.
  • 6Mothes E, Failer P. Evidence that the Principal Coll-Binding Site in Human Serum Albumin Is Not at the N-Terminus: Implication on the Albumin Cobalt Binding Test for Detecting Myocardial Ischemia. Biochemistry,2007,46(8).- 2 267-2 274.
  • 7Maguire OC, O'Sullivan J, Ryan J, et al. Evaluation of the albumin cobalt binding (ACB) assay for measurement of ischaemia-modifled albumin (IMA) on the Beckman Coulter LX-20. Ann Clin Biochem, 2006,43(6) :494-499.
  • 8Beetham R, Monk C, Keating L, et al. Effects of storage at -20 degrees C on ischaemia-modified albumin results. Ann Clin Biochem,2006, 43(6) :500-502.
  • 9Bar-Or D,Rael LT, Bar Or R,et al. The cobalt albumin binding assay: insights into its mode of action. Clin Chim Acta,2008,387 (1-2),120-127 .
  • 10Govender R, De Greef J, Delport R, et al. Biological variation of ischaemia-modified albumin in healthy subjects, Cardiovasc J Afr, 2008,19(3):141-144.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部